Dow Surges 30% YTD Amid Cost-Cutting Efforts and Strategic Expansion
Dow Inc.'s DOW shares have surged by 29.9% so far this year, outperforming the Zacks Chemicals Diversified industry's 22% rise over the same time frame.
The company has been gaining from its cost-reduction and productivity improvement efforts, strategic expansion in high-growth markets, and feedstock advantages in the Americas.
Dow benefits from its differentiated portfolio and advantaged feedstock positions in the Americas, as well as its global footprint and market reach.
Despite navigating a challenging macroeconomic environment, Dow remains focused on growth actions in attractive end markets and executing high-return incremental growth projects in cost-advantaged regions.
The company has completed the shutdown of its higher-cost Barry, U.K., upstream siloxanes unit, shifting its silicones mix by more than 25% toward more stable and higher-margin businesses while maintaining value-chain integration.
This action is expected to provide about $60 million of EBITDA uplift in the second half of 2026.